CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 33232-33482 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T193","span":{"begin":0,"end":250},"obj":"Sentence"},{"id":"T7294","span":{"begin":0,"end":250},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, in vivo for its efficacy in an ALS mouse model, pharmacokinetic profile and brain penetration were investigated as well, compound 107 (1.0, 10, and 20 mg/kg) dose-dependently extended the survival of SOD1 G93A mice at the dose of 300 mg/kg."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T44","span":{"begin":41,"end":44},"obj":"Disease"},{"id":"T44427","span":{"begin":41,"end":44},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0004976"},{"id":"A8064","pred":"mondo_id","subj":"T44427","obj":"http://purl.obolibrary.org/obo/MONDO_0004976"}],"text":"Moreover, in vivo for its efficacy in an ALS mouse model, pharmacokinetic profile and brain penetration were investigated as well, compound 107 (1.0, 10, and 20 mg/kg) dose-dependently extended the survival of SOD1 G93A mice at the dose of 300 mg/kg."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T193","span":{"begin":0,"end":250},"obj":"Sentence"}],"text":"Moreover, in vivo for its efficacy in an ALS mouse model, pharmacokinetic profile and brain penetration were investigated as well, compound 107 (1.0, 10, and 20 mg/kg) dose-dependently extended the survival of SOD1 G93A mice at the dose of 300 mg/kg."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T37","span":{"begin":41,"end":44},"obj":"Phenotype"}],"attributes":[{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0007354"}],"text":"Moreover, in vivo for its efficacy in an ALS mouse model, pharmacokinetic profile and brain penetration were investigated as well, compound 107 (1.0, 10, and 20 mg/kg) dose-dependently extended the survival of SOD1 G93A mice at the dose of 300 mg/kg."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T11","span":{"begin":86,"end":91},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"Moreover, in vivo for its efficacy in an ALS mouse model, pharmacokinetic profile and brain penetration were investigated as well, compound 107 (1.0, 10, and 20 mg/kg) dose-dependently extended the survival of SOD1 G93A mice at the dose of 300 mg/kg."}